Registered entities
SYNPROMICS LTD
Reg. No. 1739278United States
Innovation
37 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport; filing pace accelerating. Cited 199 times.
| Year | Filings |
|---|---|
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 8 |
| 2025 | 22 |
| 2026 | 12 |
Social engagement
Social engagement: 47.7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include Vida Ventures, TPG; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Private equity | 2 | 33% |
| Other / undisclosed | 2 | 33% |
Hiring activity
Hires periodically
6 roles tracked across 4 of the last 12 months
10 Jun 2026 · Sr. Quality Assurance Specialist · Durham
10 Jun 2026 · VP, GDNF Clinical Development · Durham
15 Jan 2026 · Quality Control Specialist · Durham
3 Nov 2025 · IT Data Architect · Durham
22 Oct 2025 · Senior IT Business Analyst · Durham
Based on job postings tracked across public sources.
Recent activity
29 Jun 2026
Partnership
Bayer | Pharmaceuticals
26 Jun 2026
Recognition